Growth hormone (GH) treatment in thalassaemic patients with short stature, GH insufficiency and different severity of iron overload

Bone Marrow Transplantation

Volumn 19, Issue SUPPL. 2, 1997, Pages 32-33

  De Sanctis, V ^a   Urso, L ^a   Galati, M C ^a   Mangiagli, A ^a   Massolo, L ^a   Ponzi, G ^a   Ruggiero, L ^a   Sacco, M ^a   Cavallini, A R ^a   Rigolin, F ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE;

ADOLESCENT; ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HORMONAL THERAPY; HUMAN; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SCHOOL CHILD; SHORT STATURE; SUBCUTANEOUS DRUG ADMINISTRATION; THALASSEMIA;

EID: 0030951575     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (4)

1. Scacchi M., Danesi L., De Martin M. et al (1991). Treatment with biosynthetic growth hormone of short thalassaemic patients with impaired growth hormone secretion. Clin. Endocrinol 35:335-339.
2. Grundy RG, Woods KA, Savage MO and Evans JPM (1994). Relationship of endocrinopathy to iron chelation status in young patients with thalassaemia major. Arch Dis Child. 71: 128-132.
3. De Sanctis V, Atti. G, Banin P et al (1991). Growth in thalassaemia major 23: 26-36. Acta Med. Auxol. 23: 29-36.
4. Zachmann M, Rother K, Kempken B and De Sanctis V (1993). Acute metabolic effects of HGH on 15N-Nitrogen balance in GH-deficient and non-deficient children. Implication for long-term treatment. Serono Symposia 100: 51-62.